Editorial: Focusing on T-Cells for Novel Treatments of Systemic Lupus Erythematosus.

Autor: Ichinose K; Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Hedrich CM; Department of Women's and Children's Health, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom.; Division of Rheumatology and Clinical Immunology, Alder Hey Children's NHS Foundation Trust Hospital, Liverpool, United Kingdom., Moulton VR; Division of Rheumatology and Clinical Immunology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, United States., Mizui M; Department of Nephrology, Graduate School of Medicine, Osaka University, Suita, Japan.
Jazyk: angličtina
Zdroj: Frontiers in immunology [Front Immunol] 2021 Aug 06; Vol. 12, pp. 744866. Date of Electronic Publication: 2021 Aug 06 (Print Publication: 2021).
DOI: 10.3389/fimmu.2021.744866
Abstrakt: Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Databáze: MEDLINE